Mogamulizumab-kpkc Intravenous and Rosiglitazone and glimepiride
Determining the interaction of Mogamulizumab-kpkc Intravenous and Rosiglitazone and glimepiride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: glimepiride / rosiglitazone
Brand name: Avandaryl
Synonyms: Rosiglitazone and glimepiride (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Rosiglitazone and metformin
- Mogamulizumab-kpkc Intravenous-Rosiglitazone Maleate
- Mogamulizumab-kpkc Intravenous-Rosula
- Mogamulizumab-kpkc Intravenous-Rosula Cleansing Cloth
- Mogamulizumab-kpkc Intravenous-Rosula Wash
- Mogamulizumab-kpkc Intravenous-Rosuvastatin
- Rosiglitazone and glimepiride-Molindone
- Rosiglitazone and glimepiride-Mometasone (Oral Inhalation)
- Rosiglitazone and glimepiride-Mometasone and Formoterol
- Rosiglitazone and glimepiride-Mometasone and formoterol Inhalation
- Rosiglitazone and glimepiride-Mometasone Cream
- Rosiglitazone and glimepiride-Mometasone Furoate